The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
The RASSF1A tumor suppressor
Open accessAbstract
RASSF1A (Ras association domain family 1 isoform A) is a recently discovered tumor suppressor whose inactivation is implicated in the development of many human cancers. Although it can be inactivated by gene deletion or point mutations, the most common contributor to loss or reduction of RASSF1A function is transcriptional silencing of the gene by inappropriate promoter methylation. This epigenetic mechanism can inactivate numerous tumor suppressors and is now recognized as a major contributor to the development of cancer. RASSF1A lacks apparent enzymatic activity but contains a Ras association (RA) domain and is potentially an effector of the Ras oncoprotein. RASSF1A modulates multiple apoptotic and cell cycle checkpoint pathways. Current evidence supports the hypothesis that it serves as a scaffold for the assembly of multiple tumor suppressor complexes and may relay pro-apoptotic signaling by K-Ras.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
The MAP1 family of microtubule-associated proteins.
Dehmelt (2004) · Genome biology · doi:10.1186/gb-2004-6-1-204 · Cited by 972
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Whose end is destruction: cell division and the anaphase-promoting complex
Zachariae, W., & Nasmyth, K. (1999) · Genes & Development · doi:10.1101/gad.13.16.2039 · Cited by 670
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
Downward, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80061-0 · Cited by 555
Lerman, M. I., & Minna, J. D. (2000) · PubMed · Cited by 538
Apoptotic Phosphorylation of Histone H2B Is Mediated by Mammalian Sterile Twenty Kinase
Cheung, W. L., Ajiro, K., Samejima, K., Kloc, M., Cheung, P., Mizzen, C. A., Beeser, A., Etkin, L. D., Chernoff, J., Earnshaw, W. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00355-6 · Cited by 485
Katagiri, K., Maeda, A., Shimonaka, M., & Kinashi, T. (2003) · Nature Immunology · doi:10.1038/ni950 · Cited by 461
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction
St John, M. A. R., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M. L., Brownstein, D. G., Parlow, A. F., McGrath, J., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5965 · Cited by 439
The dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393
Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388
Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Control of mitochondrial permeability by Bcl-2 family members
Sharpe, J. C., Arnoult, D., & Youle, R. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.016 · Cited by 367
Identification of a Novel Ras-Regulated Proapoptotic Pathway
Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X.-F., Seed, B., & Avruch, J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00683-8 · Cited by 357
Cdc20: A WD40 Activator for a Cell Cycle Degradation Machine
Yu, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.009 · Cited by 354
PRASKOVA, M., KHOKLATCHEV, A., ORTIZ-VEGA, S., & AVRUCH, J. (2004) · Biochemical Journal · doi:10.1042/bj20040025 · Cited by 342
Rodriguez-Viciana, P., Sabatier, C., & McCormick, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4943-4954.2004 · Cited by 327
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex
Song, M. S., Song, S. J., Ayad, N. G., Chang, J. S., Lee, J. H., Hong, H. K., Lee, H., Choi, N., Kim, J., Kim, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1091 · Cited by 311
Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis
Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., & Clark, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000463200 · Cited by 289
Self-citationHuman homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity
Tao, W., Zhang, S., Turenchalk, G. S., Stewart, R. A., St John, M. A. R., Chen, W., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5960 · Cited by 263
The MAP1 family of microtubule-associated proteins
Halpain, S., & Dehmelt, L. (2006) · Genome Biology · doi:10.1186/gb-2006-7-6-224 · Cited by 261
A Quantitative Promoter Methylation Profile of Prostate Cancer
Jerónimo, C., Henrique, R., Hoque, M. O., Mambo, E., Ribeiro, F. R., Varzim, G., Oliveira, J., Teixeira, M. R., Lopes, C., & Sidransky, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0894 · Cited by 260
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Teodoridis, J. M., Hall, J., Marsh, S., Kannall, H. D., Smyth, C., Curto, J., Siddiqui, N., Gabra, H., McLeod, H. L., Strathdee, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1187 · Cited by 256
Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines
Harada, K., Toyooka, S., Maitra, A., Maruyama, R., Toyooka, K. O., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., Hay, R. J., Minna, J. D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205446 · Cited by 226
The Role of RASSF1A Methylation in Cancer
Hesson, L. B., Cooper, W. N., & Latif, F. (2007) · Disease Markers · doi:10.1155/2007/291538 · Cited by 218
Tumor Susceptibility of Rassf1a Knockout Mice
Tommasi, S., Dammann, R., Zhang, Z., Wang, Y., Liu, L., Tsark, W. M., Wilczynski, S. P., Li, J., You, M., & Pfeifer, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.92.65.1 · Cited by 214
Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X.-F., Dammann, R., Pfeifer, G. P., & Avruch, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205192 · Cited by 209
Identification of Nore1 as a Potential Ras Effector
Vavvas, D., Li, X., Avruch, J., & Zhang, X.-F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5439 · Cited by 208
Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis
Eckert, L. B., Repasky, G. A., Ülkü, A. S., McFall, A., Zhou, H., Sartor, C. I., & Der, C. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0396 · Cited by 207
RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., & Pfeifer, G. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.055 · Cited by 200
Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis
Oh, H. J., Lee, K.-K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J.-O., Yonehara, S., & Lim, D.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2951 · Cited by 196
Mitotic checkpoints: from yeast to cancer
Wassmann, K., & Benezra, R. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00161-1 · Cited by 195
Control of microtubule stability by the RASSF1A tumor suppressor
Liu, L., Tommasi, S., Lee, D.-H., Dammann, R., & Pfeifer, G. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206984 · Cited by 193
Baksh, S., Tommasi, S., Fenton, S., Yu, V. C., Martins, L. M., Pfeifer, G. P., Latif, F., Downward, J., & Neel, B. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.010 · Cited by 186
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
Saavedra, H. I., Knauf, J. A., Shirokawa, J. M., Wang, J., Ouyang, B., Elisei, R., Stambrook, P. J., & Fagin, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203723 · Cited by 186
RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor
Vos, M. D., Ellis, C. A., Elam, C., Ülkü, A. S., Taylor, B. J., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300554200 · Cited by 183
Self-citationK-ras mutations and RASSF1A promoter methylation in colorectal cancer
van Engeland, M., Roemen, G. M., Brink, M., Pachen, M. M., Weijenberg, M. P., de Bruïne, A. P., Arends, J.-W., van den Brandt, P. A., FPM de Goeij, A., & Herman, J. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205466 · Cited by 181
Shinozaki, M., Hoon, D. S. B., Giuliano, A. E., Hansen, N. M., Wang, H.-J., Turner, R., & Taback, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1810 · Cited by 169
Tögel, M., Wiche, G., & Propst, F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.695 · Cited by 159
Vos, M. D., Martinez, A., Elam, C., Dallol, A., Taylor, B. J., Latif, F., & Clark, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0339 · Cited by 159
Self-citationKuzmin, I., Gillespie, J. W., Protopopov, A. I., Geil, L., Dreijerink, K. M. A., Yang, Y., Vocke, C. D., Duh, F.-M. C., Zabarovsky, E. R., Minna, J. D., et al. (2002) · PubMed · Cited by 158
Spugnardi, M., Tommasi, S., Dammann, R., Pfeifer, G. P., & Hoon, D. S. �. (2003) · PubMed · Cited by 153
Tan, K. O., Tan, K. M. L., Chan, S. L., Yee, K. S. Y., Bévort, M., Ang, K. C., & Yu, V. C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008955200 · Cited by 152
The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
Polesello, C., Huelsmann, S., Brown, N. H., & Tapon, N. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.060 · Cited by 151
The Ras Effector RASSF2 Is a Novel Tumor-Suppressor Gene in Human Colorectal Cancer
Akino, K., Toyota, M., Suzuki, H., Mita, H., Sasaki, Y., Ohe-Toyota, M., Issa, J. J., Hinoda, Y., Imai, K., & Tokino, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.051 · Cited by 148
RASSF6 is a novel member of the RASSF family of tumor suppressors
Allen, N. P. C., Donninger, H., Vos, M. D., Eckfeld, K., Hesson, L. B., Gordon, L. E., Birrer, M. J., Latif, F., & Clark, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210440 · Cited by 146
Self-citationRASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Dallol, A., Agathanggelou, A., Fenton, S. L., Ahmed-Choudhury, J., Hesson, L. B., Vos, M. D., Clark, G., Downward, J., Maher, E. R., & Latif, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0267 · Cited by 146
Self-citationThe RASSF1A Tumor Suppressor Activates Bax via MOAP-1
Vos, M. D., Dallol, A., Eckfeld, K., Allen, N. P. C., Donninger, H., Hesson, L. B., Calvisi, D. F., Latif, F., & Clark, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512128200 · Cited by 143
Self-citationPromoter Hypermethylation Profile of Ovarian Epithelial Neoplasms
Makarla, P., Saboorian, M. H., Ashfaq, R., Toyooka, K. O., Toyooka, S., Minna, J. D., Gazdar, A. F., & Schorge, J. O. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2455 · Cited by 142
Dammann, R., Schagdarsurengin, U., Strunnikova, M., Rastetter, M., Seidel, C., Liu, L., Tommasi, S., & Pfeifer, G. P. (2003) · PubMed · doi:10.14670/hh-18.665 · Cited by 139
Caretaker tumour suppressor genes that defend genome integrity
Levitt, N. C., & Hickson, I. D. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02298-0 · Cited by 138
Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors
Pfeifer, G. P., & Dammann, R. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0151-y · Cited by 137
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
Astuti, D., Agathanggelou, A., Honorio, S., Dallol, A., Martinsson, T., Kogner, P., Cummins, C., Neumann, H. P. H., Voutilainen, R., Dahia, P. L. M., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204968 · Cited by 137
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers
Hesson, L. B., Dallol, A., Minna, J. D., Maher, E. R., & Latif, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206191 · Cited by 130
Hesson, L. B., Bièche, I., Krex, D., Crinière, E., Hoang‐Xuan, K., Maher, E. R., & Latif, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207407 · Cited by 128
Hwang, E., Ryu, K., Pääkkönen, K., Güntert, P., Cheong, H., Lim, D., Lee, J., Jeon, Y. H., & Cheong, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610716104 · Cited by 127
The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung
Vos, M. D., Martínez, A., Ellis, C. A., Vallecorsa, T., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211019200 · Cited by 125
Self-citationA novel inter action motif, SARAH, connects three classes of tumor suppressor
Scheel, H., & Hofmann, K. (2003) · Current Biology · doi:10.1016/j.cub.2003.11.007 · Cited by 124
Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System
Safar, A. M., Spencer, H. J., Su, X., Coffey, M., Cooney, C. A., Ratnasinghe, L. D., Hutchins, L. F., & Fan, C. Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2378 · Cited by 124
RASSF4/AD037 Is a Potential Ras Effector/Tumor Suppressor of the RASSF Family
Eckfeld, K., Hesson, L. B., Vos, M. D., Bièche, I., Latif, F., & Clark, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2065 · Cited by 120
Self-citationTommasi, S., Dammann, R., Jin, S., Zhang, X., Avruch, J., & Pfeifer, G. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205365 · Cited by 115
Chen, J., Lui, W., Vos, M. D., Clark, G. J., Takahashi, M., Schoumans, J., Khoo, S. K., Petillo, D., Lavery, T. T., Sugimura, J., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00269-1 · Cited by 114
Self-citationYabuta, N., Fujii, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Nishiguchi, H., Endo, Y., Toji, S., Tanaka, H., Nishimune, Y., et al. (2000) · Genomics · doi:10.1006/geno.1999.6065 · Cited by 112
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors
Nakamura, N., Carney, J. A., Jin, L. G., Kajita, S., Pallarés, J., Zhang, H., Qian, X., Sebo, T. J., Erickson, L. A., & Lloyd, R. V. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700306 · Cited by 111
Armesilla, A. L., Williams, J. C., Buch, M. H., Pickard, A., Emerson, M., Cartwright, E. J., Oceandy, D., Vos, M. D., Gillies, S., Clark, G. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307557200 · Cited by 111
Self-citationMultigene methylation analysis of Wilms' tumour and adult renal cell carcinoma
Morris, M. R., Hesson, L. B., Wagner, K. J., Morgan, N. V., Astuti, D., Lees, R. D., Cooper, W. N., Lee, J., Gentle, D., MacDonald, F., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206914 · Cited by 108
Chan, M. W. Y., Chan, L. W., Tang, N. L. S., Lo, K. W., TONG, J. H. M., Chan, A. W. H., Cheung, H. Y., Wong, W. S., Chan, P. S. F., Lai, F. M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10971 · Cited by 102
Liu, L., Broaddus, R. R., Yao, J. C., Xie, S.-S., White, J. A., Wu, T., Hamilton, S. R., & Rashid, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800490 · Cited by 102
Rong, R., Jin, W., Zhang, J., Sheikh, M. S., & Huang, Y. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207901 · Cited by 102
Schagdarsurengin, U., Gimm, O., Dralle, H., Hoang‐Vu, C., & Dammann, R. (2006) · Thyroid · doi:10.1089/thy.2006.16.633 · Cited by 101
The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis
van der Weyden, L., Tachibana, K.-E. K., Gonzalez, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8356-8367.2005 · Cited by 99
Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong, S. M., Sun, D., Benoit, N. E., et al. (2003) · PubMed · Cited by 98
Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabé-Ortiz, J. C., Lopez-Ilasaca, M. A., Khokhlatchev, A. V., Mollahan, P., Pfeifer, G. P., Avruch, J., & Seed, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401699200 · Cited by 93
Hogg, R., Honorio, S., Martinez, A., Agathanggelou, A., Dallol, A., Fullwood, P., Weichselbaum, R. R., Kuo, M., Maher, E. R., & Latif, F. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00422-1 · Cited by 91
Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration
Dallol, A., Agathanggelou, A., Tommasi, S., Pfeifer, G. P., Maher, E. R., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0247 · Cited by 89
Nore1 and RASSF1 Regulation of Cell Proliferation and of the MST1/2 Kinases
Avruch, J., Praskova, M. D., Ortiz-Vega, S., Liu, M., & Zhang, X. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07025-4 · Cited by 86
Lusher, M. E., Lindsey, J. C., Latif, F., Pearson, A. D. J., Ellison, D. W., & Clifford, S. C. (2002) · PubMed · doi:10.25405/ncl.34605555 · Cited by 85
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
Miranda, E., Destro, A., Malesci, A., Balladore, E., Bianchi, P. P., Baryshnikova, E., Franchi, G., Morenghi, E., Laghi, L., Gennari, L., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603337 · Cited by 85
Johan, M. F., Bowen, D., Frew, M. E., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05412.x · Cited by 84
Ura, S., Nishina, H., Gotoh, Y., & Katada, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00199-07 · Cited by 83
RASSF1A Suppresses the c-Jun-NH2-Kinase Pathway and Inhibits Cell Cycle Progression
Whang, Y. M., Kim, Y. H., Kim, J. S., & Yoo, Y. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2792 · Cited by 82
Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer
Wagner, K. J., Cooper, W. N., Grundy, R. G., Caldwell, G. M., Jones, C., Wadey, R., Morton, D. G., Schofield, P. N., Reik, W., Latif, F., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205922 · Cited by 81
Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors
Horiguchi, K., Tomizawa, Y., Tosaka, M., Ishiuchi, S., Kurihara, H., Mori, M., & Saito, N. (2003) · Oncogene · doi:10.1038/sj.onc.1207082 · Cited by 77
Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation
Kitagawa, D., Kajiho, H., Negishi, T., Ura, S., Watanabe‐Asaka, T., Wada, T., Ichijo, H., Katada, T., & Nishina, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601212 · Cited by 74
Yu, M., TONG, J. H. M., Chan, P. K. S., Lee, T., Chan, M. W. Y., Chan, A. W. H., Lo, K. W., & To, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11051 · Cited by 71
Song, M. S., Chang, J. S., Song, S. J., Yang, T. H., Lee, H., & Lim, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409115200 · Cited by 68
Haplotype mapping of the bronchiolitis susceptibility locus near IL8
Hull, J., Rowlands, K., Lockhart, E., Sharland, M., Moore, C. E., Hanchard, N. A., & Kwiatkowski, D. P. (2004) · Human Genetics · doi:10.1007/s00439-003-1038-x · Cited by 61
Analysis of ovarian cancer cell lines using array‐based comparative genomic hybridization
Lambros, M. B. K., Fiegler, H., Jones, A., Gorman, P. A., Roylance, R. R., Carter, N. P., & Tomlinson, I. P. M. (2004) · The Journal of Pathology · doi:10.1002/path.1681 · Cited by 61
Liu, L., Vo, A., & McKeehan, W. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3896 · Cited by 61
Carcinogen Exposure and Epigenetic Silencing in Bladder Cancer
Marsit, C. J., Karagas, M. R., Schned, A. R., & Kelsey, K. T. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1371.031 · Cited by 60
The E4F Protein Is Required for Mitotic Progression during Embryonic Cell Cycles
Cam, L. L., Lacroix, M., Ciemerych, M. A., Sardet, C., & Siciński, P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6467-6475.2004 · Cited by 60
Epigenetic Instability and Chromosomal Instability in Hepatocellular Carcinoma
Katoh, H., Shibata, T., Kokubu, A., Ojima, H., Fukayama, M., Kanai, Y., & Hirohashi, S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050989 · Cited by 58
Irimia, M., Fraga, M. F., Sánchez‐Céspedes, M., & Esteller, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207914 · Cited by 58
Identification of RASSF8 as a candidate lung tumor suppressor gene
Falvella, F. S., Manenti, G., Spinola, M., Pignatiello, C., Conti, B., Pastorino, U., & Dragani, T. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209422 · Cited by 57
Oliveíra, C., Velho, S., Domingo, E., Preto, A., Hofstra, R. M. W., Hamelin, R., Yamamoto, H., Seruca, R., & Schwartz, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208906 · Cited by 57
Cyclin A Is a Mediator of p120 E4F -Dependent Cell Cycle Arrest in G 1
Fajas, L., Paul, C., Vié, A., Estrach, S., Medema, R. H., Blanchard, J. M., Sardet, C., & Vignais, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2956-2966.2001 · Cited by 55
Mammalian Sterile 20–Like Kinases in Tumor Suppression: An Emerging Pathway
O’Neill, E. E., Matallanas, D., & Kölch, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1453 · Cited by 54
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma
Hamilton, D. W., Lusher, M. E., Lindsey, J. C., Ellison, D. W., & Clifford, S. C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.044 · Cited by 51
Wong, M., Tao, Q., Fu, L., Wong, K., Qiu, G., Law, F. B. F., Tin, V. P., Cheung, W.-L., Lee, P.-Y., Tang, J. C. O., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.767 · Cited by 36
Liu, L., Baier, K., Dammann, R., & Pfeifer, G. P. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4435 · Cited by 34
Tan, S. H., Ida, H., Goh, B. C., Hsieh, W.-S., Loh, M. C. S., & Ito, Y. (2006) · PubMed · Cited by 20
Stabilization and Functional Modulation of Microtubules by Microtubule-Associated Protein 4
Nguyen, H., Gruber, D., McGraw, T. E., Sheetz, M. P., & Bulinski, J. C. (1998) · Biological Bulletin · doi:10.2307/1543111 · Cited by 18
Hasan, M. R., Jin, M., Matsushima, K., Miyamoto, S., Kotani, S., & Nakagawa, H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.028 · Cited by 11
Cited by
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Epithelial cell polarity, stem cells and cancer
Martin-Belmonte, F., & Perez-Moreno, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3169 · Cited by 552
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
Regulation of cell migration by dynamic microtubules
Kaverina, I., & Straube, A. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.017 · Cited by 277
Metadata
- Authors
- Donninger, H., Vos, M. D., & Clark, G. J.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2007-09-15
- Volume
- 120
- Issue
- 18
- Pages
- 3163-3172
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2139526606
- Cited by
- 440
- References
- 112
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.